We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

23 hedge funds and large institutions have $2.51M invested in OncoSec Medical Incorporated in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 25 → 23 (-2)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

35% less capital invested

Capital invested by funds: $3.86M → $2.51M (-$1.35M)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$9.41K
2
VF
Virtu Financial
New York
+$8.16K
3
TRCT
Tower Research Capital (TRC)
New York
+$5.11K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.32K
5
TAM
Tocqueville Asset Management
New York
+$691

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$25.3K
2
DADC
D.A. Davidson & Co
Montana
-$12K
3
BlackRock
BlackRock
New York
-$9.75K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$9.59K
5
Renaissance Technologies
Renaissance Technologies
New York
-$3.76K

ONCS Hedge Fund Activity: Q3 2022 in Review

23 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q3 2022, worth a combined $2.51M — down 35% from $3.86M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ONCS and 1 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was Susquehanna International Group, adding an estimated $9.41K. The largest seller was Citadel Advisors, cutting an estimated $25.3K.

  • 23 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q3 2022, down from 25 in Q2 2022.
  • Funds reported $2.51M of OncoSec Medical Incorporated stock for Q3 2022, down 35% quarter-over-quarter.
  • 1 fund opened new OncoSec Medical Incorporated positions in Q3 2022 and 3 closed out, a net change of -2 holders.
  • The largest OncoSec Medical Incorporated buyer in Q3 2022 was Susquehanna International Group, an estimated $9.41K added.
  • The largest OncoSec Medical Incorporated seller in Q3 2022 was Citadel Advisors, an estimated $25.3K sold.

Based on aggregated 13F filings for Q3 2022.